Welcome to our dedicated page for Eldorado Gold news (Ticker: EGO), a resource for investors and traders seeking the latest updates and insights on Eldorado Gold stock.
Eldorado Gold Corporation reports on gold and base metals mining, development and exploration operations in Canada, Türkiye and Greece. Recurring updates cover operating and financial results, production and cost outlooks, capital allocation, mine development, exploration activity and governance changes across assets such as Lamaque, Skouries, Kisladag, Efemcukuru and Olympias.
The company’s news also includes project and permitting developments, including the Ormaque deposit at the Lamaque Complex, and completed portfolio actions such as the acquisition of Foran Mining, which added the McIlvenna Bay copper-zinc-gold-silver asset in Canada. Eldorado’s common shares trade on the Toronto Stock Exchange and the New York Stock Exchange under EGO in the United States.
Eldorado Gold (EGO) announced on March 16, 2026 that it received the Operating Authorization for the Ormaque deposit at the Lamaque Complex in Val-d’Or, Quebec.
Ormaque can now deliver high-grade underground ore to the Sigma Mill, supports sequencing with Triangle ore, and complements ongoing exploration (new SE, West and Garnet zones) and Sigma mill expansion studies to potentially raise throughput from ~2,500 tpd toward a fully permitted 5,000 tpd.
Eldorado (NYSE American: EGO) mailed a joint management information circular for shareholder meetings tied to its proposed combination with Foran and recommends shareholder approval of the Eldorado Share Issuance Resolution.
The Transaction positions Eldorado for near-term growth with Skouries and McIlvenna Bay advancing to commercial production in Q4 2026 and mid-2026, and projects ~$2.1B EBITDA and ~$1.5B free cash flow in 2027.
Eldorado Gold (NYSE: EGO) announced that its Lamaque Complex in Val-d'Or, Québec received the TSM Gold Leadership Award after achieving Level AAA across all applicable TSM indicators, and was certified in full compliance with the International Cyanide Management Code.
Only five other facilities have earned this recognition to date, and this is the first award since 2020. Eldorado says TSM protocols are embedded in its Sustainability Integrated Management System.
Eldorado Gold (NYSE:EGO) provided 2026 guidance and a three-year outlook targeting higher production and cash flow. Total 2026 gold production is guided at 490,000–590,000 oz; 2027 guidance rises to 620,000–720,000 oz, implying ~40% growth vs 2025. Skouries first concentrate is delayed to early Q3 2026 with commercial production expected in Q4 2026, adding copper and material cash flow.
2026 operations AISC is $1,670–1,870/oz, operations growth capital is $375–405M, Skouries project capital is $175–185M, and exploration is $75–85M.
Eldorado Gold (NYSE:EGO) reported full‑year 2025 results with 488,268 oz gold production, revenue of $1.82B, and cash & equivalents of $869.4M at December 31, 2025. Free cash flow was −$232.9M for 2025 but $315.6M excluding Skouries capital.
Skouries construction reached 78% of phase 2 and first concentrate production is expected in early Q3 2026; total Skouries capital to date was $980.0M.
Eldorado Gold (NYSE:EGO) will acquire Foran Mining in a court-approved plan of arrangement, creating a gold‑copper producer with pro‑forma scale and near‑term growth.
Consideration: 0.1128 Eldorado shares + US$0.01 cash per Foran share (implied Foran equity ~C$3.8B). Pro‑forma ownership: ~76% Eldorado / ~24% Foran. Combined 2027 guidance: ~900k gold‑eq oz, ~$2.1B EBITDA, ~$1.5B free cash flow. Skouries and McIlvenna Bay on budget and on schedule for commercial production in mid‑2026. Closing expected Q2 2026, subject to customary approvals.
Eldorado Gold (NYSE: EGO) announced multiple new high-grade discoveries at the Lamaque Complex (Quebec) and Olympias (Greece), plus a new gold-copper skarn at Stratoni, and expanded licence activity in Turkiye. Key assay highlights include multi-metre intercepts above 10 g/t Au at Ormaque SE and Ormaque West, Olympias NW intercepts within 200 m of infrastructure, and a 42.75 m skarn intercept with copper. The company plans to increase its 2026 exploration budget to $75–$85 million and target ~80,000–90,000 m of drilling at Lamaque-Bourlamaque, with 18,000 m at Ormaque and further underground and regional programs.
Eldorado Gold (NYSE: EGO) announced a new quarterly dividend program with an initial dividend of US$0.075 per share, payable March 13, 2026, to holders of record on February 27, 2026. The dividend is designated as an eligible dividend for Canadian tax purposes and will be paid in US dollars except for registered Canadian residents who will receive Canadian dollars using the Bank of Canada daily average exchange rate on the February 27, 2026 record date.
The company noted the dividend and an ongoing share repurchase program (approximately US$204 million repurchased and cancelled in 2025) reflect its capital return framework, but future dividends remain at the Board’s discretion and subject to financial performance and debt covenants.
Eldorado Gold (NYSE:EGO) provided a Greece update: Skouries expects first concentrate late Q1 2026 and commercial production mid-2026, with overall project progress at 90% (phase 2 at 78%) as of Dec 31, 2025. The company reports a $1.06 billion Q1 2025 capital estimate, with the €680.4 million loan facilities fully drawn. Cumulative phase 2 capital invested was ~$980 million. Open pit and underground stockpiles total ~1.2 Mt containing ~47.3k oz gold and 12.5M lb copper. Olympias mill expansion to 650k tpa is on track for Q3–Q4 2026 ramp-up. Perama Hill EIA submitted Dec 2025; feasibility update underway.
Eldorado Gold (NYSE:EGO) reported preliminary 2025 gold production of 488,268 oz and Q4 2025 production of 123,418 oz. Key assets: Lamaque 187,208 oz (Q4 49,307 oz), Kisladag 168,701 oz (Q4 41,141 oz), Efemcukuru 72,482 oz (Q4 14,497 oz) and Olympias 59,877 oz (Q4 18,473 oz).
Lamaque delivered year‑over‑year strength and has produced ~1.12M oz since 2019. Olympias improved processing stability, raising Q4 output ~36% vs Q3. Efemcukuru met annual guidance for the 11th consecutive year despite Q4 grade sequencing. The company appointed Dr. Sally Eyre to the board (effective Jan 1, 2026) and will release full 2025 results and 2026 guidance on Feb 19, 2026 with a conference call on Feb 20, 2026.